Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

overall survival

  • Open Access
    Long-term Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients With Relapsed/Refractory Multiple Myeloma
    JOON YOUNG HUR, HAN-SEUNG PARK, YUNSUK CHOI, HYUNKYUNG PARK, YU-EUN LEE, JISOO JEONG, SEUNGAH CHA, EUN-JI CHOI, JE-HWAN LEE, YOUNG-SHIN LEE, MIJIN JEON, JI MIN WOO, YOUNG-AH KANG, HYERAN KANG and JUNG-HEE LEE
    In Vivo March 2026, 40 (2) 1007-1018; DOI: https://doi.org/10.21873/invivo.14256
  • Open Access
    Prognostic Superiority of the White Cell-to-Lymphocyte Ratio (WLR) in Predicting Overall Survival in Patients With Gliomas
    XIAO ZHANG, GUILAN CAI, HEYANG ZHANG and YONGBO ZHANG
    In Vivo March 2026, 40 (2) 1163-1173; DOI: https://doi.org/10.21873/invivo.14271
  • Open Access
    Clinicopathological Features and Prognostic Impact of Microscopic Resection Margin Positivity After Curative Gastrectomy for Gastric Cancer
    TORU AOYAMA, HARUHIKO CHO, HIDEAKI SUEMATSU and KENTARO HARA
    In Vivo March 2026, 40 (2) 954-962; DOI: https://doi.org/10.21873/invivo.14251
  • Open Access
    Albumin-bilirubin (ALBI) and Platelet-ALBI (PALBI) Grades: Novel Prognostic Factors for Cholangiocellular Carcinoma
    ERGİN AYDEMİR, FUNDA YILMAZ, ALPER TÜRKEL, ÖZTÜRK ATEŞ and MUTLU DOĞAN
    In Vivo September 2025, 39 (5) 2976-2985; DOI: https://doi.org/10.21873/invivo.14098
  • Open Access
    Prognostic Significance of Inflammation-based Scores in Pancreatic Cancer Patients Treated With Palliative Chemotherapy: A Single Institution Experience
    MARIÁN LIBERKO, TOMÁŠ SYCHRA, MARTIN OLIVERIUS and RENATA SOUMAROVÁ
    In Vivo November 2024, 38 (6) 2782-2794; DOI: https://doi.org/10.21873/invivo.13758
  • Open Access
    Colon Cancer With Bladder Invasion: A Single Center Experience
    TZU-WEI CHIANG, LI-WEN CHANG, FENG-FAN CHIANG, JIAN-RI LI and SHENG-CHUN HUNG
    In Vivo November 2024, 38 (6) 2990-3001; DOI: https://doi.org/10.21873/invivo.13782
  • Open Access
    Can Platelet-to-Lymphocyte Ratio (PLR) and Neutrophil-to-Lymphocyte Ratio (NLR) Help Predict Outcomes of Patients With Recurrent Glioblastoma?
    OKSANA ZEMSKOVA, NATHAN Y. YU, JAN LEPPERT, ANASTASSIA LÖSER and DIRK RADES
    In Vivo September 2024, 38 (5) 2341-2348; DOI: https://doi.org/10.21873/invivo.13700
  • Open Access
    Impact of PD-L1 Expression on the Overall Survival of Patients With Non-small Cell Lung Cancer Treated With Single-agent Pembrolizumab
    MARTIN SVATON, MAGDALENA KNETKI-WROBLEWSKA, SYLWIA TABOR, PETR DOMECKY, ONDREJ VENCLICEK, JANA KREJCI, MARIE DROSSLEROVA, MICHAL HRNCIARIK, DANIEL HRICISAK, ALZBETA BEJCKOVA, ONDREJ FISCHER, MARTINA VITKOVA and MACIEJ KRZAKOWSKI
    In Vivo September 2024, 38 (5) 2434-2440; DOI: https://doi.org/10.21873/invivo.13712
  • Open Access
    The Role of Radiotherapy for Meningeal Melanocytomas – A 20 Year Update
    DIRK RADES, OKSANA ZEMSKOVA, JAN GLIEMROTH and NATHAN Y. YU
    In Vivo May 2024, 38 (3) 1220-1228; DOI: https://doi.org/10.21873/invivo.13558
  • Open Access
    Chemotherapy With Eribulin Following Potentially Curative Surgery in Patients With Localized Liposarcoma
    OSKAR STEINBRECHER, THOMAS BRODOWICZ, PETAR POPOV and WOLFGANG LAMM
    In Vivo January 2024, 38 (1) 385-389; DOI: https://doi.org/10.21873/invivo.13450

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
In Vivo

© 2026 In Vivo

Powered by HighWire